For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks.

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a ...

Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $646.73 today based on a ...

Elevance Health, Inc. ( NYSE:ELV ) received a lot of attention from a substantial price movement on the NYSE over ...

This quarter, Elevance Health grew its revenue by 6.6% year on year, and its $45.44 billion of revenue was in line with Wall Street’s estimates. Looking ahead, sell-side analysts expect revenue to ...

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded ...

GreensKeeper Asset Management, an investment management company, released its fourth quarter investor letter. A copy of the ...

Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a ...

Verily, an Alphabet (GOOG) (GOOGL) precision health company ... Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio Published first ...

Shares of Elevance Health Inc. ELV slipped 2.91% to $390.47 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.36% to ...

UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records ...